United States Biosimilar Insulin Market Report 2017

United States Biosimilar Insulin Market Report 2017

1 Biosimilar Insulin Overview

1.1 Product Overview and Scope of Biosimilar Insulin

1.2 Classification of Biosimilar Insulin by Product Category

1.2.1 United States Biosimilar Insulin Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Biosimilar Insulin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Rapid Acting Insulins

1.2.4 Short Acting Insulins

1.2.5 Intermediate Insulins

1.2.6 Long Lasting Insulins

1.3 United States Biosimilar Insulin Market by Application/End Users

1.3.1 United States Biosimilar Insulin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Medical Center

1.4 United States Biosimilar Insulin Market by Region

1.4.1 United States Biosimilar Insulin Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Biosimilar Insulin Status and Prospect (2012-2022)

1.4.3 Southwest Biosimilar Insulin Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Biosimilar Insulin Status and Prospect (2012-2022)

1.4.5 New England Biosimilar Insulin Status and Prospect (2012-2022)

1.4.6 The South Biosimilar Insulin Status and Prospect (2012-2022)

1.4.7 The Midwest Biosimilar Insulin Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Biosimilar Insulin (2012-2022)

1.5.1 United States Biosimilar Insulin Sales and Growth Rate (2012-2022)

1.5.2 United States Biosimilar Insulin Revenue and Growth Rate (2012-2022)

2 United States Biosimilar Insulin Market Competition by Players/Suppliers

2.1 United States Biosimilar Insulin Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Biosimilar Insulin Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Biosimilar Insulin Average Price by Players/Suppliers (2012-2017)

2.4 United States Biosimilar Insulin Market Competitive Situation and Trends

2.4.1 United States Biosimilar Insulin Market Concentration Rate

2.4.2 United States Biosimilar Insulin Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Biosimilar Insulin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Biosimilar Insulin Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Biosimilar Insulin Sales and Market Share by Region (2012-2017)

3.2 United States Biosimilar Insulin Revenue and Market Share by Region (2012-2017)

3.3 United States Biosimilar Insulin Price by Region (2012-2017)

4 United States Biosimilar Insulin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Biosimilar Insulin Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Biosimilar Insulin Revenue and Market Share by Type (2012-2017)

4.3 United States Biosimilar Insulin Price by Type (2012-2017)

4.4 United States Biosimilar Insulin Sales Growth Rate by Type (2012-2017)

5 United States Biosimilar Insulin Sales (Volume) by Application (2012-2017)

5.1 United States Biosimilar Insulin Sales and Market Share by Application (2012-2017)

5.2 United States Biosimilar Insulin Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Biosimilar Insulin Players/Suppliers Profiles and Sales Data

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Biosimilar Insulin Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Biogenomics

6.2.2 Biosimilar Insulin Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Biogenomics Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Eli Lilly

6.3.2 Biosimilar Insulin Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Eli Lilly Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Gan&Lee Pharmaceuticals

6.4.2 Biosimilar Insulin Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Geropharm

6.5.2 Biosimilar Insulin Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Geropharm Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Julphar Gulf Pharmaceutical Industries

6.6.2 Biosimilar Insulin Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Paras Biopharmaceuticals

6.7.2 Biosimilar Insulin Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Paras Biopharmaceuticals Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Samsung Bioepis

6.8.2 Biosimilar Insulin Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Samsung Bioepis Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Sedico

6.9.2 Biosimilar Insulin Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Sedico Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Wockhardt

6.10.2 Biosimilar Insulin Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Wockhardt Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Teva Pharmaceuticals

7 Biosimilar Insulin Manufacturing Cost Analysis

7.1 Biosimilar Insulin Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Biosimilar Insulin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Biosimilar Insulin Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Biosimilar Insulin Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Biosimilar Insulin Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Biosimilar Insulin Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Biosimilar Insulin Sales Volume Forecast by Type (2017-2022)

11.3 United States Biosimilar Insulin Sales Volume Forecast by Application (2017-2022)

11.4 United States Biosimilar Insulin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Biosimilar Insulin

Figure United States Biosimilar Insulin Market Size (K Pcs) by Type (2012-2022)

Figure United States Biosimilar Insulin Sales Volume Market Share by Type (Product Category) in 2016

Figure Rapid Acting Insulins Product Picture

Figure Short Acting Insulins Product Picture

Figure Intermediate Insulins Product Picture

Figure Long Lasting Insulins Product Picture

Figure United States Biosimilar Insulin Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Biosimilar Insulin by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Medical Center Examples

Table Key Downstream Customer in Medical Center

Figure United States Biosimilar Insulin Market Size (Million USD) by Region (2012-2022)

Figure The West Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Biosimilar Insulin Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Biosimilar Insulin Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Biosimilar Insulin Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Biosimilar Insulin Sales Share by Players/Suppliers

Figure 2017 United States Biosimilar Insulin Sales Share by Players/Suppliers

Figure United States Biosimilar Insulin Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Biosimilar Insulin Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Biosimilar Insulin Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Biosimilar Insulin Revenue Share by Players/Suppliers

Figure 2017 United States Biosimilar Insulin Revenue Share by Players/Suppliers

Table United States Market Biosimilar Insulin Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Biosimilar Insulin Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Biosimilar Insulin Market Share of Top 3 Players/Suppliers

Figure United States Biosimilar Insulin Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Biosimilar Insulin Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Biosimilar Insulin Product Category

Table United States Biosimilar Insulin Sales (K Pcs) by Region (2012-2017)

Table United States Biosimilar Insulin Sales Share by Region (2012-2017)

Figure United States Biosimilar Insulin Sales Share by Region (2012-2017)

Figure United States Biosimilar Insulin Sales Market Share by Region in 2016

Table United States Biosimilar Insulin Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Biosimilar Insulin Revenue Share by Region (2012-2017)

Figure United States Biosimilar Insulin Revenue Market Share by Region (2012-2017)

Figure United States Biosimilar Insulin Revenue Market Share by Region in 2016

Table United States Biosimilar Insulin Price (USD/Pcs) by Region (2012-2017)

Table United States Biosimilar Insulin Sales (K Pcs) by Type (2012-2017)

Table United States Biosimilar Insulin Sales Share by Type (2012-2017)

Figure United States Biosimilar Insulin Sales Share by Type (2012-2017)

Figure United States Biosimilar Insulin Sales Market Share by Type in 2016

Table United States Biosimilar Insulin Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Biosimilar Insulin Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Biosimilar Insulin by Type (2012-2017)

Figure Revenue Market Share of Biosimilar Insulin by Type in 2016

Table United States Biosimilar Insulin Price (USD/Pcs) by Types (2012-2017)

Figure United States Biosimilar Insulin Sales Growth Rate by Type (2012-2017)

Table United States Biosimilar Insulin Sales (K Pcs) by Application (2012-2017)

Table United States Biosimilar Insulin Sales Market Share by Application (2012-2017)

Figure United States Biosimilar Insulin Sales Market Share by Application (2012-2017)

Figure United States Biosimilar Insulin Sales Market Share by Application in 2016

Table United States Biosimilar Insulin Sales Growth Rate by Application (2012-2017)

Figure United States Biosimilar Insulin Sales Growth Rate by Application (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Pfizer Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Pfizer Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Biogenomics Basic Information List

Table Biogenomics Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Biogenomics Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Biogenomics Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Biogenomics Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Eli Lilly Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Eli Lilly Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Eli Lilly Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Gan&Lee Pharmaceuticals Basic Information List

Table Gan&Lee Pharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Geropharm Basic Information List

Table Geropharm Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Geropharm Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Geropharm Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Geropharm Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Julphar Gulf Pharmaceutical Industries Basic Information List

Table Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Paras Biopharmaceuticals Basic Information List

Table Paras Biopharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Paras Biopharmaceuticals Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Paras Biopharmaceuticals Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Paras Biopharmaceuticals Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Samsung Bioepis Basic Information List

Table Samsung Bioepis Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Samsung Bioepis Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Samsung Bioepis Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Samsung Bioepis Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Sedico Basic Information List

Table Sedico Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sedico Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Sedico Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Sedico Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Wockhardt Basic Information List

Table Wockhardt Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Wockhardt Biosimilar Insulin Sales Growth Rate (2012-2017)

Figure Wockhardt Biosimilar Insulin Sales Market Share in United States (2012-2017)

Figure Wockhardt Biosimilar Insulin Revenue Market Share in United States (2012-2017)

Table Teva Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biosimilar Insulin

Figure Manufacturing Process Analysis of Biosimilar Insulin

Figure Biosimilar Insulin Industrial Chain Analysis

Table Raw Materials Sources of Biosimilar Insulin Major Players/Suppliers in 2016

Table Major Buyers of Biosimilar Insulin

Table Distributors/Traders List

Figure United States Biosimilar Insulin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Biosimilar Insulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Biosimilar Insulin Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Biosimilar Insulin Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Biosimilar Insulin Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Biosimilar Insulin Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Biosimilar Insulin Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Biosimilar Insulin Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Biosimilar Insulin Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Biosimilar Insulin Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Biosimilar Insulin Sales Volume Share Forecast by Region (2017-2022)

Figure United States Biosimilar Insulin Sales Volume Share Forecast by Region (2017-2022)

Figure United States Biosimilar Insulin Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources